PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New bitter blocker discovered

Serendipitous finding increases understanding of taste, opening doors to better nutrition and therapeutic compliance

2011-06-03
(Press-News.org) PHILADELPHIA (June 2, 2011) -- Although bitterness can sometimes be desirable – such as in the taste of coffee or chocolate – more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. This is especially true for children. Now, scientists from the Monell Center and Integral Molecular describe the discovery of a compound that inhibits bitterness by acting directly on a subset of bitter taste receptors.

"Bitter taste is a major problem for pediatric drug compliance and also for proper nutrition, such as eating those healthy but bitter green vegetables," said Monell senior author Paul Breslin, Ph.D., a sensory biologist. "But we currently have very limited ways to effectively control bitter taste."

Bitterness is detected by a family of approximately 25 different taste receptors called TAS2Rs. Together, the TAS2Rs respond to a broad array of structurally different compounds, many of which are found in nature and can be toxic.

Discovery of bitter blockers would help scientists understand the signaling mechanisms of these receptors and promote the design of novel and more effective blockers.

Monell and Integral Molecular are collaborating on a large project to understand the structure and function of TAS2Rs. In a serendipitous discovery, the researchers found that probenecid, a molecule frequently used in receptor assays, is an inhibitor of a subset of bitter taste receptors. Probenecid also is an FDA-approved therapeutic for gout.

In the study, published in PLoS ONE, a series of in vitro studies revealed that probenecid does not physically block interaction of bitter molecules with the receptor's primary binding site. Rather, it appears to bind elsewhere on the receptor to modulate the receptor's ability to interact with the bitter molecule.

"Probenecid's mechanism of action makes it a useful tool for understanding how bitter receptors function," said Integral Molecular senior author Joseph B. Rucker, Ph.D. "This knowledge will help us develop more potent bitter taste inhibitors."

A series of human sensory studies established that probenecid robustly inhibited the bitter taste of salicin, a compound that stimulates one of the target receptors.

"This demonstrates how we can take in vitro experiments and go on to show how they make a difference functionally and perceptually," said Breslin.

Additional studies will continue to explore the structure and function of TAS2Rs. The overall goal is to identify the regions of the receptors that contribute to bitter molecule binding and how binding events lead to signaling events within the cell.

Understanding modulation of bitter receptor function may have additional implications for the respiratory and gastrointestinal systems, as bitter taste receptors also are expressed in the nose, the lungs and the intestines.

INFORMATION:

Also contributing to the research were first author Tiffani A. Greene, Anu Thomas, Eli Berdougo, and Benjamin J. Doranz of Integral Molecular, and Suzanne Alarcon of Rutgers University School of Environmental and Biological Sciences. Dr. Breslin is also faculty at Rutgers University School of Environmental and Biological Sciences. The research was funded by the National Institute on Deafness and Other Communication Disorders.

The Monell Chemical Senses Center is an independent nonprofit basic research institute based in Philadelphia, Pennsylvania. Monell advances scientific understanding of the mechanisms and functions of taste and smell to benefit human health and well-being. Using an interdisciplinary approach, scientists collaborate in the programmatic areas of sensation and perception; neuroscience and molecular biology; environmental and occupational health; nutrition and appetite; health and well-being; development, aging and regeneration; and chemical ecology and communication. For more information about Monell, visit www.monell.org.

Integral Molecular is a biotechnology company committed to providing innovative solutions for scientific research and drug discovery applications involving integral membrane proteins. Integral Molecular is a privately-owned company founded in 2001 and located in central Philadelphia. The company has been working with pharmaceutical, biotechnology and academic customers and collaborators since its inception, providing membrane protein related products and services that advance its customers' scientific objectives. For more information about Integral Molecular, visit www.integralmolecular.com.

END



ELSE PRESS RELEASES FROM THIS DATE:

Are Debt Collectors Your "Friends?" Social Networks and Debt Collection

2011-06-03
The Federal Trade Commission recently held a seminar entitled "Debt Collection 2.0" and among the usual discussions of debt collection was a new topic: "Using Social Media for Debt Collection: Consumer Information, Collector Communications, and Privacy Issues." Using social media, like Facebook and Twitter for debt collection purposes is something new. Joel Winston of the FTC told MSNBC, "We have received a few complaints about collectors who are using social media to either impersonate the person's friends or otherwise use it for harassment." Social ...

Antifungal drug delays need for chemo in advanced prostate cancer

2011-06-03
The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease. Details of the finding, from a clinical trial led by Johns Hopkins experts, are scheduled for presentation on Saturday, June 4 at the 2011 American Society of Clinical Oncology (ASCO) annual meeting (abstract #4532). Currently, the drug is approved to treat fungal infections in nails and other organs. Serious side effects can include heart failure, and Johns Hopkins experts caution that ...

Novel 'prodrug' alleviates symptoms in Huntington's and Alzheimer's mice

2011-06-03
A study in a special early online publication of Cell, a Cell Press publication, reveals a promising new slow-release compound that protects mice against the neurodegenerative effects of both Huntington's and Alzheimer's disease. The 'prodrug' known only as JM6 works through a pathway involved in the breakdown of the amino acid tryptophan. Surprisingly, JM6 delivers those benefits even though it doesn't cross the blood-brain barrier and therefore cannot act directly on the brain. "Most would have assumed that the drug would have to enter the brain to have an effect," ...

Utah Bicyclists Honor the Fallen in 'Ride of Silence'

2011-06-03
Thousands of events are scheduled across the nation to celebrate the joys and traditions that come with riding bicycles. While most events are geared to welcome spring and summertime activities, some, like the Bike Bonanza in downtown Salt Lake City, promote healthy living and efficiency. Another national event, the Ride of Silence, is dedicated to reminding people about bicycle safety and honoring those killed in bicycle accidents. Each year since 2003, riders have gathered on the third Wednesday of May to bring awareness to the hazards bicyclists endure from motorists. ...

People who have had head injuries report more violent behavior

2011-06-03
AUDIO: University of Michigan School of Public Health researcher Stoddard's research shows a link between violent behavior and brain injury in youth. Click here for more information. ANN ARBOR, Mich.---Young people who have sustained a head injury during their lifetime are more likely to engage in violent behavior, according to an eight-year study from the University of Michigan School of Public Health. Further, the research found that young people who suffered a recent ...

Partnership between autism experts, pediatricians identifies toddlers at risk for autism

2011-06-03
(SALT LAKE CITY)—Parents and health care providers can't always tell whether toddlers display signs of autism syndrome disorder (ASD), but new research from the University of Utah shows that a significant portion of at-risk children between 14-24 months can be identified through systematic screening by autism experts and providers working together. Identifying children with ASD as young as possible is critical for the early intervention that can improve their lives and ability to function in the world. But a systematic way to do that has not been established, according ...

Study finds copper proves effective against new E. coli strains

2011-06-03
As the World Health Organisation suggests the E. coli outbreak in Germany is a strain never before seen in an outbreak – O104:H4 – laboratory science conducted at the University of Southampton indicates a role for copper in preventing the spread of such infections. Professor Bill Keevil, Head of the Microbiology Group and Director of the Environmental Healthcare Unit at the University of Southampton, explains: "A study looking at copper's efficacy against new strains of E. coli has just been completed. Although it did not specifically look at O104, all the strains investigated ...

UofL researchers uncover mechanism in saliva production

2011-06-03
LOUISVILLE, Ky. – University of Louisville researchers are one step closer to helping millions of people whose salivary glands no longer work because of disease or damage from treatment of diseases. The scientific finding of Douglas Darling, PhD, professor, Department of Oral Health and Rehabilitation, UofL School of Dentistry, and his team identified a protein sorting mechanism used by the salivary gland. The National Institutes of Health supported study published on-line first this week in the Journal of Dental Research. The scientific discovery could form the ...

Scripps Research scientists find way to block stress-related cell death

2011-06-03
Scientists from the Florida campus of The Scripps Research Institute have uncovered a potentially important new therapeutic target that could prevent stress-related cell death, a characteristic of neurodegenerative diseases such as Parkinson's, as well as heart attack and stroke. In the study, published recently in the journal ACS Chemical Biology, the scientists showed they could disrupt a specific interaction of a critical enzyme that would prevent cell death without harming other important enzyme functions. The enzyme in question is c-jun-N-terminal kinase (JNK), ...

Wrong-Site Surgery: What Is It and Why Does It Happen?

2011-06-03
Wrong-site surgery is a one of the most preventable forms of medical malpractice because it is so unnecessary. It indicates sloppiness in procedure and a level of inattention to detail you would hope to never find in a surgeon or their staff. While there are often explanations, there is never any excuse. It might be excusable in an emergency military hospital, with surgeons operating under a crush of battle injured patients, but it should simply never occur in a modern hospital. A statement from the website of the American Academy of Orthopaedic Surgeons notes: "Wrong-site ...

LAST 30 PRESS RELEASES:

Plastic pollution could linger at ocean surfaces for over a century, new research finds

TU Graz conducts research into endangered cultural heritage in the Western Himalayas

AI can be trained to provide safe advice for treating opioid use disorder in pregnancy: New study

A platform of gold reveals the forces of nature’s invisible glue

Drug which stops tumors' blood supply could help kids with bone cancer live longer

Disrupted sleep in teens identified as suicide risk factor

Traffic noise joins land clearance as damaging to bird survival

Innovative online monitoring system for farmland non-point source pollution enables automated monitoring of continuous cropping farmland

Stabilized fertilizers improve nitrogen use efficiency and reduce greenhouse gas emissions

Endangered Kangaroo Island ground dweller found in trees

Guardians of the coast: Philippine scientists unlock the climate power of mangroves in Eastern Visayas

Nano-biochar helps rice roots turn silver ions into less toxic nanoparticles

New ‘liquid metal’ composite material enables recyclable, flexible and reconfigurable electronics

Extinction rates have slowed across many plant and animal groups, study shows

Tiny fossil bone helps unlock history of the bowerbird

AI tool beats humans at detecting parasites in stool samples, Utah study finds

Innovative biochar research to boost circular economy: Join live talk by Prof. Salah Jellali on October 29

Early life sugar restriction linked to lasting heart benefits in adulthood

The Lancet: Study confirms cardiovascular benefits of semaglutide beyond weight loss

‘Weight loss’ drug helps heart regardless of amount of weight lost

First truly global picture of wide inequalities in care for women’s cancers

International Consortium of Women’s Mental Health Experts present scientific evidence to support classification of postpartum psychosis as a distinct disease

PET imaging of inflammation predicts recovery, guides therapy after heart attack

Pennington Biomedical awarded renewal of NIH-funded Center to Advance Metabolic Disease Research and train future scientists

Planetary scientists link Jupiter’s birth to Earth’s formation zone

University of Louisville, UofL Health receive $11.5 million to develop new cancer immunotherapies

Survey: Californians don’t know cannabis driving laws

Gum disease and cavities linked to increased stroke risk

Gum disease associated with changes in the brain

Brian Cleary awarded $2.25 million NIH grant to advance single-cell gene expression research

[Press-News.org] New bitter blocker discovered
Serendipitous finding increases understanding of taste, opening doors to better nutrition and therapeutic compliance